Open access
1,593
Views
38
CrossRef citations to date
0
Altmetric
Reviews
Entry inhibitors: New advances in HCV treatment
Xi-Jing QianShanghai Key Laboratory of Medical Biodefense, Department of Microbiology, Second Military Medical University, Shanghai200433, China
, Yong-Zhe ZhuShanghai Key Laboratory of Medical Biodefense, Department of Microbiology, Second Military Medical University, Shanghai200433, China
, Ping ZhaoShanghai Key Laboratory of Medical Biodefense, Department of Microbiology, Second Military Medical University, Shanghai200433, China
& Zhong-Tian QiShanghai Key Laboratory of Medical Biodefense, Department of Microbiology, Second Military Medical University, Shanghai200433, ChinaCorrespondence[email protected]
Pages 1-8
|
Received 10 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.